Antigua and Barbuda vs South Asia: Immunization, Hib3
Antigua and Barbuda
99.0%
in 2024
South Asia
94.5%
in 2024
Antigua and Barbuda rank
1st
South Asia rank
1st
Immunization, Hib3 over time
- Antigua and Barbuda
- South Asia
How they compare
Antigua and Barbuda currently reports 99.0% against 94.5% in South Asia, a difference of 4.5%.
Across all 24 years both countries report, Antigua and Barbuda has been ahead every year.
Antigua and Barbuda ranks 1st and South Asia ranks 1st of 191 countries.
Antigua and Barbuda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | South Asia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 97.3% | 1.2% | 96.1% | Antigua and Barbuda |
| 2010s | 97.3% | 50.6% | 46.7% | Antigua and Barbuda |
| 2020s | 97.4% | 90.6% | 6.8% | Antigua and Barbuda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Antigua and Barbuda or South Asia?
- Antigua and Barbuda, at 99.0% against 94.5% in South Asia as of 2024.
- What is the difference in immunization, hib3 between Antigua and Barbuda and South Asia?
- 4.5%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and South Asia?
- 24 years are reported by both, from 2001 to 2024.
- How do Antigua and Barbuda and South Asia rank globally for immunization, hib3?
- Antigua and Barbuda ranks 1st and South Asia ranks 1st of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.